Emmett, Matthew J.
Lazar, Mitchell A.
Article History
First Online: 2 November 2018
Competing interests
: M.A.L. is a consultant to KDAC, a company developing histone deacetylase (HDAC) inhibitors, and Novartis, and serves on scientific advisory boards for Pfizer and Eli Lilly and Co.